Alliance Global Partners Weighs in on Tilray FY2025 Earnings

Tilray Inc (NASDAQ:TLRY - Free Report) - Stock analysts at Alliance Global Partners lowered their FY2025 earnings estimates for Tilray in a report issued on Wednesday, April 9th. Alliance Global Partners analyst A. Grey now anticipates that the company will earn ($1.02) per share for the year, down from their prior forecast of ($0.18). The consensus estimate for Tilray's current full-year earnings is ($0.20) per share.

Other equities analysts have also issued research reports about the stock. Piper Sandler dropped their target price on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a research report on Wednesday, April 9th. Canaccord Genuity Group raised their price objective on Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research report on Monday, January 13th. Finally, Roth Capital reaffirmed a "neutral" rating on shares of Tilray in a report on Monday.

Tilray Price Performance

TLRY traded down $0.03 during trading on Monday, reaching $0.45. 44,059,783 shares of the company traded hands, compared to its average volume of 29,393,479. The company has a market cap of $421.94 million, a P/E ratio of -1.50 and a beta of 1.88. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. Tilray has a 12-month low of $0.43 and a 12-month high of $2.52. The firm has a fifty day simple moving average of $0.67 and a 200 day simple moving average of $1.13.

Tilray (NASDAQ:TLRY - Get Free Report) last announced its quarterly earnings data on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The business had revenue of $185.78 million during the quarter, compared to analysts' expectations of $213.38 million.

Institutional Trading of Tilray

A number of large investors have recently made changes to their positions in TLRY. California State Teachers Retirement System lifted its holdings in shares of Tilray by 8.0% in the 4th quarter. California State Teachers Retirement System now owns 778,513 shares of the company's stock valued at $1,035,000 after acquiring an additional 57,544 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Tilray by 317.7% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 166,326 shares of the company's stock valued at $221,000 after purchasing an additional 126,507 shares during the last quarter. Toronto Dominion Bank boosted its holdings in shares of Tilray by 53.0% in the 4th quarter. Toronto Dominion Bank now owns 197,207 shares of the company's stock worth $260,000 after purchasing an additional 68,284 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Tilray by 17.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,964,380 shares of the company's stock valued at $2,613,000 after purchasing an additional 286,481 shares during the last quarter. Finally, Two Sigma Advisers LP increased its position in shares of Tilray by 81.7% during the 4th quarter. Two Sigma Advisers LP now owns 164,800 shares of the company's stock valued at $219,000 after purchasing an additional 74,100 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.